Jacquelyn M Powers1, Margaret Nagel2, Jean L Raphael3, Donald H Mahoney4, George R Buchanan5, Deborah I Thompson6. 1. Department of Pediatrics, Baylor College of Medicine, Houston, TX; Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX. Electronic address: jmpowers@texaschildrens.org. 2. Texas Children's Hospital, Houston, TX. 3. Department of Pediatrics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX. 4. Department of Pediatrics, Baylor College of Medicine, Houston, TX; Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX. 5. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX. 6. Department of Pediatrics, Baylor College of Medicine, Houston, TX; United States Department of Agriculture, Agricultural Research Center, Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX.
Abstract
OBJECTIVE: To characterize barriers to and facilitators of successful iron therapy in young children with iron deficiency anemia (IDA) from an in-depth parental perspective. STUDY DESIGN: Prospective, mixed methods study of children age 9 months to 4 years with a diagnosis of nutritional IDA by clinical history and laboratory criteria and their parents. Clinical data were obtained from the electronic health record. Semistructured interviews focused on knowledge of IDA, clinical effects, experience with iron therapies, and motivation were conducted with the parent who identified as the child's primary caregiver. RESULTS: Twenty patient-parent dyads completed the study; 80% (n = 16) identified as Hispanic/Latino (white). Patients' median age was 23 months (50% male); median initial hemoglobin concentration was 8.2 g/dL and duration of oral iron therapy was 3 months. Parents' median age was 29 years (85% female); 8 interviews (40%) were conducted in Spanish. Barriers included difficulty in administering oral iron owing to side effects and poor taste. Facilitators included provision of specific instructions; support from healthcare providers and additional caregivers at home; motivation to benefit child's health, which was strengthened by strong emotional reactions (ie, stress, anxiety) to therapy and follow-up; and an appreciation of child's improvement with successful completion of therapy. CONCLUSIONS: Our findings support the need for interventions designed to promote oral iron adherence in children with IDA. Rather than focusing on knowledge content related to IDA, interventions should aim to increase parental motivation by emphasizing the health benefits of adhering to iron therapy and avoiding more invasive interventions.
OBJECTIVE: To characterize barriers to and facilitators of successful iron therapy in young children with iron deficiency anemia (IDA) from an in-depth parental perspective. STUDY DESIGN: Prospective, mixed methods study of children age 9 months to 4 years with a diagnosis of nutritional IDA by clinical history and laboratory criteria and their parents. Clinical data were obtained from the electronic health record. Semistructured interviews focused on knowledge of IDA, clinical effects, experience with iron therapies, and motivation were conducted with the parent who identified as the child's primary caregiver. RESULTS: Twenty patient-parent dyads completed the study; 80% (n = 16) identified as Hispanic/Latino (white). Patients' median age was 23 months (50% male); median initial hemoglobin concentration was 8.2 g/dL and duration of oral iron therapy was 3 months. Parents' median age was 29 years (85% female); 8 interviews (40%) were conducted in Spanish. Barriers included difficulty in administering oral iron owing to side effects and poor taste. Facilitators included provision of specific instructions; support from healthcare providers and additional caregivers at home; motivation to benefit child's health, which was strengthened by strong emotional reactions (ie, stress, anxiety) to therapy and follow-up; and an appreciation of child's improvement with successful completion of therapy. CONCLUSIONS: Our findings support the need for interventions designed to promote oral iron adherence in children with IDA. Rather than focusing on knowledge content related to IDA, interventions should aim to increase parental motivation by emphasizing the health benefits of adhering to iron therapy and avoiding more invasive interventions.
Authors: Jacquelyn M Powers; Catherine L Daniel; Timothy L McCavit; George R Buchanan Journal: Pediatr Blood Cancer Date: 2016-01-05 Impact factor: 3.167
Authors: Miriam Santer; Hana Burgess; Lucy Yardley; Steven J Ersser; Sue Lewis-Jones; Ingrid Muller; Catherine Hugh; Paul Little Journal: J Adv Nurs Date: 2013-03-25 Impact factor: 3.187
Authors: Sarah H O'Brien; Sherif M Badawy; Seth J Rotz; Mona D Shah; Julie Makarski; Rachel S Bercovitz; Mary-Jane S Hogan; Lori Luchtman-Jones; Julie A Panepinto; Ginna M Priola; Char M Witmer; Julie A Wolfson; Marianne Yee; Lisa K Hicks Journal: Blood Adv Date: 2022-01-25
Authors: Vikram Kalathur Raghu; Krishnapriya M Prathapan; Megan E Hamm; Jeffrey A Rudolph; Marie K Norman Journal: J Pediatr Gastroenterol Nutr Date: 2021-03-01 Impact factor: 3.288